Telehealth General Psychiatry Prescribing: What Prescribers Can Do in North Carolina

You went to school to treat patients, not navigate 50 different sets of prescribing rules. Yet here we are — psychiatrists wondering if they can start stimulants via video, PMHNPs trying to figure out if they need a physician to co-sign their buprenorphine scripts, and everyone Googling ‘can I prescribe controlled substances through telehealth in [State]?’ at 11 PM.

If you’re a psychiatric prescriber — whether you’re an MD, DO, or PMHNP — the regulatory landscape for telehealth prescribing in 2026 is simultaneously better and more complicated than ever. The good news: telepsychiatry is here to stay, and federal flexibilities have kept controlled substance prescribing alive online through at least the end of 2025. The challenge: state laws still vary wildly, especially for nurse practitioners, and the rules governing what you can prescribe, to whom, and under what supervision change every time you cross a state line.

This guide breaks down what you actually need to know: what psychiatrists and PMHNPs can prescribe via telehealth, how scope of practice differs between MDs and NPs by state, and what the reimbursement landscape looks like for medication management in 2026. Whether you’re practicing in California, Texas, Florida, New York, Pennsylvania, or Illinois — or thinking about adding those states to your telehealth practice — this is your roadmap.

Can Psychiatrists Prescribe Controlled Substances Via Telehealth? (Yes, But Read This)

Let’s start with the question that keeps psychiatrists up at night: Can I prescribe Schedule II stimulants, benzodiazepines, or buprenorphine through a video visit?

The short answer in 2026: Yes — for now.

Here’s why: The federal Ryan Haight Act normally requires an in-person medical evaluation before prescribing controlled substances. But since March 2020, the DEA has waived that requirement under public health emergency provisions. As of February 2026, those telehealth flexibilities remain in place, extended through December 31, 2025, and widely expected to continue in some form given the political and clinical reality of telemental health (texasnp.org) (natlawreview.com).

What this means practically:

• You can initiate a new patient on Adderall, Vyvanse, Xanax, or Suboxone via a telehealth visit without having seen them in person first
• You can manage ongoing controlled substance prescriptions entirely remotely
• This applies to all psychiatrists nationwide with a valid DEA registration, regardless of state

But — and this is critical — the DEA has proposed permanent rules that could re-impose some in-person requirements or create special registration pathways for telehealth prescribing. The final rules have been delayed repeatedly, but they’re coming. Most experts predict they’ll include exceptions for mental health treatment or at least a 30-day initial supply allowance, but nothing is guaranteed (www.nixonpeabody.com).

So here’s what you should do:

• Prescribe confidently under current federal allowances — this is legal and standard of care as of 2026
• Stay subscribed to DEA updates (or join a platform like Klarity that handles regulatory monitoring for you)
• Be prepared to potentially require an initial in-person visit if rules change (though grandfathered patients would likely be exempt)

State-level wrinkles:

While federal law sets the floor, states can add restrictions. Most states have aligned with federal telehealth allowances for mental health, but there are notable exceptions:

• Florida: Explicitly permits controlled substance prescribing via telehealth for psychiatric treatment — one of the most permissive statutes in the country (www.flsenate.gov). Florida carved out mental health from its general prohibition on teleprescribing for chronic pain. So you can start a Florida patient on Adderall for ADHD via video without an in-person visit.

• Texas: Allows telemedicine prescribing of controlled substances except for Schedule II narcotics for chronic pain (www.cchpca.org). For psychiatric treatment (ADHD, anxiety, OUD), you’re good to go via telehealth. Texas also requires you to check the state’s Prescription Monitoring Program (PMP) before prescribing any controlled substance.

• New York: Just finalized regulations in mid-2025 aligning state law with federal telehealth allowances (www.nixonpeabody.com). Previously there was ambiguity, but now NY psychiatrists can prescribe controlled substances via telehealth consistent with DEA rules. Caveat: Medicare patients in NY may eventually need an in-person visit every 6-12 months (this is a Medicare billing rule under discussion, not a prescribing ban).

• California: No state-level ban on telehealth controlled substance prescribing. California requires a ‘good faith exam’ before prescribing, but telehealth explicitly satisfies that requirement (natlawreview.com). You must check CURES (California’s PMP) before prescribing Schedule II–IV medications.

Bottom line for psychiatrists: You have broad authority to prescribe via telehealth in 2026, including controlled substances, in virtually every state. The wild card is what happens when the DEA finalizes its permanent rules — but for now, this is the most permissive environment telepsychiatry has ever had.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs. Psychiatrist Prescribing Authority: The State-by-State Reality

Here’s where things get messy.

Psychiatrists have full, independent prescribing authority in all 50 states. If you’re an MD or DO with a medical license and DEA registration, you can prescribe any psychiatric medication without anyone looking over your shoulder.

Psychiatric nurse practitioners? It depends on where your patient is sitting.

As of 2026, about 34 states grant NPs ‘Full Practice Authority’ (FPA) — meaning they can evaluate, diagnose, and prescribe independently, including controlled substances (www.nursepractitioneronline.com). The other 16 states still require some level of physician collaboration or supervision.

If you’re a PMHNP practicing via telehealth, this creates a compliance maze. Let’s break it down by our priority states:

California: Transitioning to Independence (Almost There)

Psychiatrists: Fully independent.

PMHNPs: California is in the middle of a phased rollout toward NP independence via AB 890 (passed 2020).

• New NPs still need physician-supervised ‘standardized procedures’ (essentially protocol agreements outlining their scope)
• Experienced NPs (3+ years post-certification) can become ‘103 NPs’ as of 2023 — this allows them to practice in group settings without direct supervision (www.rn.ca.gov)
• By January 2026, those experienced NPs can apply for ‘104 NP’ status, which grants full independent practice — including solo practice and full prescriptive authority (www.rn.ca.gov)

What this means: If you’re a new-grad PMHNP in California, you need a collaborating psychiatrist. If you’ve got 3+ years of experience, you’re basically independent by 2026. California is effectively becoming a full-practice state, which is huge given it’s the largest state by population.

Reimbursement note: Medicare pays NPs at 85% of physician rates (www.nursepractitioneronline.com), but some private payers in CA are moving toward parity.

Texas: Restricted Practice (Physician Supervision Required Forever)

Psychiatrists: Fully independent.

PMHNPs: Texas is one of the most restrictive states for NPs. No pathway to independence, ever (www.bon.texas.gov).

• PMHNPs must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe anything
• The physician must be available for consultation and conduct regular meetings (monthly for the first 3 years, then quarterly)
• One physician can supervise a maximum of 7 NPs/PAs (capitol.texas.gov)
• Schedule II controlled substances: Texas law historically barred NPs from prescribing Schedule II outpatient except in very limited cases (terminally ill patients, some pediatric ADHD exceptions) (www.cchpca.org). In practice, many Texas PMHNPs have the supervising physician write initial stimulant prescriptions.

What this means: If you’re a PMHNP on a telehealth platform serving Texas patients, you cannot practice independently. You need a Texas-licensed physician collaborator. This is a major barrier for solo practice but less of an issue if you’re joining a platform like Klarity that provides supervising physicians as part of the infrastructure.

Workforce context: Texas has one of the worst psychiatrist-to-population ratios in the country (1 per ~8,500 residents), with 614 psychiatrists needed to eliminate mental health shortage areas (www.healingpsychiatryflorida.com). The demand for prescribers is massive, even with the regulatory friction.

Florida: Restricted for Psych NPs (Primary Care NPs Got Independence, We Didn’t)

Psychiatrists: Fully independent.

PMHNPs: Florida passed HB 607 in 2020, creating ‘autonomous APRN’ status — but only for primary care NPs (family medicine, internal medicine, pediatrics) (www.npschools.com). Psychiatric NPs were explicitly excluded.

Bills have been introduced since then (e.g., HB 771 in 2024) to extend autonomy to PMHNPs, but as of 2026, they still require physician supervision (www.flsenate.gov).

Here’s the twist: Florida defines a ‘psychiatric nurse’ as a PMHNP with an MSN/DNP in psychiatric nursing and 2+ years of supervised experience under a psychiatrist. These psychiatric nurses can prescribe psychotropic controlled substances for mental health treatment without the 7-day supply limit that applies to other NPs prescribing Schedule II medications (www.flsenate.gov).

What this means: Florida PMHNPs can prescribe stimulants, benzos, etc., for psychiatric conditions (unlike, say, a family NP managing chronic pain), but they still need a psychiatrist collaborator. The good news is Florida’s telehealth law explicitly allows controlled substance prescribing for mental health (www.flsenate.gov), so you can do this work remotely as long as you have the supervision in place.

Workforce context: Florida has ~7.8 million people in mental health shortage areas (www.healingpsychiatryflorida.com). Demand is sky-high.

New York: Reduced Practice Transitioning to Independence After 3,600 Hours

Psychiatrists: Fully independent.

PMHNPs: New York has one of the most provider-friendly NP laws in the country, thanks to the NP Modernization Act (2015, made permanent in 2022).

• New PMHNPs must practice under a written collaborative agreement with a physician for the first 3,600 hours (~2 years full-time) (www.jdsupra.com)
• After 3,600 hours, they can practice independently — no written agreement, no chart co-signing, no supervision (www.jdsupra.com)
• They must attest to having a ‘collaborative relationship’ with physicians (basically, ‘I know some doctors I can call if I need help’), but it’s not a formal supervisory relationship

What this means: New York is effectively a full-practice state for experienced NPs. If you’re a PMHNP with 2+ years of experience, you can open your own practice, prescribe independently (including controlled substances), and bill directly. This has been a game-changer for telehealth platforms serving NY — PMHNPs can handle the same patient load as psychiatrists once they hit that threshold.

Telehealth bonus: New York just finalized rules explicitly allowing controlled substance prescribing via telehealth, aligned with federal DEA waivers (www.nixonpeabody.com).

Pennsylvania: Restricted Practice (Collaboration Required, No Independence)

Psychiatrists: Fully independent.

PMHNPs: Pennsylvania requires collaborative agreements indefinitely — there is no pathway to independence yet (www.pacnp.org).

• The agreement must be filed with the PA Board of Nursing
• It must specify which medications the NP can prescribe (including whether they can prescribe controlled substances)
• The collaborating physician must review a percentage of the NP’s charts regularly (often 10%+ every 3 months)
• Schedule II prescriptions by NPs are limited to 30-day supply and the physician must be notified within 24 hours (www.pacnp.org)

What this means: PMHNPs in Pennsylvania cannot practice solo. They need a physician collaborator, which can be challenging (and sometimes expensive — physicians may charge collaboration fees). Legislation to grant full practice authority has been introduced but hasn’t passed as of 2026.

Workforce context: Pennsylvania has moderate psychiatrist density in urban areas (Philadelphia, Pittsburgh) but significant rural shortages — about 99 psychiatrists needed statewide to eliminate shortage areas (www.healingpsychiatryflorida.com).

Illinois: Reduced Practice with Pathway to Full Independence After 4,000 Hours

Psychiatrists: Fully independent.

PMHNPs: Illinois allows NPs to apply for Full Practice Authority after completing 4,000 hours of practice under physician collaboration plus 250 hours of continuing education in pharmacology (www.nursepractitionerlicense.com).

• Until you hit FPA, you must have a Written Collaborative Agreement with a physician
• Your prescriptions must list the delegating physician’s name
• After FPA, you can prescribe independently, including controlled substances (you need to apply for a mid-level controlled substance registration)

What this means: Illinois is a transitional state — if you’re early-career, you need supervision; if you’ve got 2-3 years of experience, you can practice independently. This is similar to New York’s model and has been successful in expanding access.

Unique quirk: Illinois also allows clinical psychologists with specialized training to prescribe a limited formulary of mental health medications under psychiatrist supervision — one of only a handful of states to do this (www.weisszarett.com).

Reimbursement: Illinois mandates private payer telehealth payment parity through at least 2027 for behavioral health, so you’ll get paid the same for video visits as in-person.

Collaborative Practice Agreements: What They Actually Require (And What They Cost)

If you’re a PMHNP in a restricted or reduced-practice state, you’ll need a collaborative practice agreement (CPA). Here’s what that typically involves:

Required elements:

• Scope definition: What conditions you can treat, what medications you can prescribe (often excludes certain drug classes or age groups)
• Chart review: Physician must review X% of your charts (ranges from 10% monthly in some states to 100% for Schedule II prescriptions)
• Availability: Physician must be available for consultation (by phone, within X hours)
• Meetings: Some states require regular face-to-face meetings (Texas: monthly for 3 years, then quarterly; Pennsylvania: typically twice/year)
• State board filing: Some states require submitting the CPA to the nursing board for approval

The hidden cost:

Many physicians charge PMHNPs for collaboration — anywhere from $500/month to $2,000/month depending on state, specialty, and level of involvement required. Some require a percentage of billings (10-20%). This can be a significant barrier for NPs trying to start independent practices.

For telehealth platforms: This is less of an issue if you’re joining a network like Klarity Health, which typically provides supervising physicians as part of the infrastructure. You get to see patients without the administrative headache or cost of finding your own collaborator.

States with the tightest requirements:

• Texas: Caps one physician to 7 NPs max, requires monthly meetings initially
• Florida: Requires psychiatrist collaborator specifically for psychiatric NPs prescribing psychotropics
• Pennsylvania: Requires chart co-signing and biannual meetings

Medication Management Reimbursement: What You’ll Actually Get Paid

Let’s talk money. If you’re doing psychiatric medication management via telehealth, here’s what reimbursement looks like in 2026:

Medicare Rates (National Average)

These are the baseline most providers reference:

• 90792 (Initial psychiatric diagnostic evaluation with medication management, ~60 min): ~$173 (therathink.com)
• 99213 (15-min follow-up med check, established patient): ~$95 (therathink.com)
• 99214 (25-min follow-up, moderate complexity): ~$136 (therathink.com)
• 99215 (40-min follow-up, high complexity): ~$192 (therathink.com)

For NPs: Medicare pays 85% of physician rates when billed under the NP’s NPI (www.nursepractitioneronline.com). So a 99213 that pays a psychiatrist $95 pays an NP about $81.

Private Insurance

Commercial rates vary wildly by region and insurer but typically exceed Medicare:

• Major insurers in high-cost areas might pay $150 for a 99213 and $200+ for a 99214
• Some plans pay NPs at parity with physicians; others maintain the 85-90% differential
• Telehealth parity laws in most states now require equal reimbursement for telehealth vs. in-person — this is huge

States with strong parity mandates:

• California: AB 744 requires payment parity for telehealth (effective 2021)
• Illinois: SB 667 mandates equal reimbursement through 2027
• New York: Requires telehealth coverage, though rate negotiations vary by payer

Texas note: Texas has telehealth coverage laws but no mandated payment parity — in practice, though, most insurers pay equal rates for tele-mental health due to market demand (www.cchpca.org).

Medicaid

Medicaid rates are typically lower than Medicare but come with high patient volume:

• Rates vary by state (Florida Medicaid might pay $60-80 for a med check; California Medi-Cal around 75% of Medicare)
• Many states have enhanced rates for behavioral health or care coordination models
• Telehealth parity: Most state Medicaids now reimburse telehealth at the same rate as in-person (New York, Pennsylvania, Illinois all do)

Cash Pay / Direct-to-Consumer

Many psychiatrists, especially in high-demand specialties like ADHD treatment, opt out of insurance entirely:

• Typical cash rates: $100-200 for a 15-20 min follow-up, $200-400 for an initial eval
• No billing overhead, no claim denials, immediate payment
• Downside: limits your patient pool to those who can afford out-of-pocket

Klarity’s model note: If you’re joining a telehealth platform, check whether they’re insurance-based or cash-pay. Insurance-based platforms handle credentialing and billing (less hassle, lower per-visit revenue but higher volume). Cash-pay platforms typically offer higher per-appointment fees but may have more variable patient flow.

The Economics of Patient Acquisition: Why Platforms Beat DIY Marketing

Here’s what nobody tells you when you’re starting out: acquiring psychiatric patients on your own is expensive and slow.

Let’s be brutally honest about what DIY marketing actually costs:

The Real Cost of Acquiring Patients Independently

SEO (Search Engine Optimization):

• Takes 6-12 months of consistent investment before generating meaningful patient flow
• Requires ongoing content creation, technical optimization, backlink building
• Typical cost: $1,500-3,000/month for a professional SEO agency, or hundreds of hours of your own time
• Most solo providers don’t have the expertise or patience for this

Google Ads (PPC):

• Mental health keywords cost $15-40+ per click
• Most clicks don’t convert to booked patients (click-through rates are typically 2-5%, and only 10-20% of those book)
• Realistic cost per booked patient: $200-400+ when you factor in wasted ad spend on clicks that don’t convert
• Requires constant optimization and budget testing

Directory Listings:

• Psychology Today: ~$30/month subscription, but you’re competing with hundreds of other providers on the same search results page. Conversion rates are low unless you’re in a very specific niche.
• Zocdoc: Charges $35-100+ per booking (varies by market), PLUS a monthly subscription fee. Total monthly cost can hit $500-1,500 depending on volume.
• You still need to handle lead qualification, no-shows, and cancellations

True Total Cost:

When you add it all up — agency/consultant fees, ad spend, failed campaigns, staff time to handle and qualify leads, no-show rates from cold leads, months of investment before results — you’re looking at $200-500+ per acquired patient for most solo providers trying to build a practice from scratch.

And that’s if you’re successful. Many providers spend $3,000-5,000/month on marketing for 6+ months before seeing meaningful ROI.

Why Platforms Make Economic Sense

Compare that to a pay-per-appointment model like Klarity Health uses:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You only pay when you see patients — guaranteed ROI vs. gambling on marketing channels

The math:

Let’s say Klarity charges a standard listing fee per new patient lead (similar to Zocdoc’s per-booking model, but typically more competitive because it’s purpose-built for psychiatric care). Even if that fee is $50-100 per new patient, you’re getting:

• A qualified patient who’s already been screened
• No wasted time on no-shows from unqualified leads
• No months of marketing investment before seeing your first patient
• Consistent patient flow without ongoing ad spend

Compare that to spending $3,000/month on Google Ads with uncertain results, and the platform model starts to look like the smart choice — especially when you’re starting out or scaling.

For established providers with existing patient flow: DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience. But for most providers, especially those starting out or trying to scale quickly, a platform that handles patient acquisition removes the risk entirely and lets you focus on what you do best: treating patients.

State-by-State Quick Reference: Prescribing Rules for Priority States

Practical Takeaways: What This Means for Your Practice

If you’re a psychiatrist:

1. You can prescribe virtually anything via telehealth in 2026 — including controlled substances — under current federal waivers
2. Stay alert for DEA rule changes (expected by late 2024), but don’t let uncertainty stop you from serving patients now
3. Check state PMPs before prescribing controlled substances (required in most states)
4. Document thoroughly — telehealth visits require the same clinical rigor as in-person, plus documentation of patient location and consent

If you’re a PMHNP:

1. Know your state’s scope-of-practice rules — this determines whether you can practice independently or need a collaborator
2. If you’re in a restricted state (TX, FL, PA), joining a platform that provides supervising physicians is the fastest path to seeing patients
3. If you’re in a transitional state (NY, IL, CA), put in your 2-3 years under supervision and then enjoy full independence
4. If you’re in a full-practice state, congratulations — you can operate like a psychiatrist (though Medicare still pays 85%)

For everyone:

Telehealth reimbursement is stable and favorable in 2026. Medicare and most state Medicaids pay at parity with in-person visits. Private insurers in most states are legally required to do the same. The financial viability of telepsychiatry is no longer in question.

Patient acquisition is the real bottleneck. You can either spend months and thousands of dollars building your own marketing funnel, or you can join a platform that delivers pre-qualified patients and handles

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship